796 related articles for article (PubMed ID: 25440329)
21. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
22. A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan.
Beer C; Blacker D; Bynevelt M; Hankey GJ; Puddey IB
Int J Stroke; 2012 Feb; 7(2):104-11. PubMed ID: 22044557
[TBL] [Abstract][Full Text] [Related]
23. Prediction for rupture risk of carotid artery plaques: A comparative study of 3D-GSM and CAS system.
Zhang M; Zhao Q; Gao Y; Wu X; Wang J
Eur J Radiol; 2016 Sep; 85(9):1659-65. PubMed ID: 27501903
[TBL] [Abstract][Full Text] [Related]
24. Atorvastatin in stroke: a review of SPARCL and subgroup analysis.
Huisa BN; Stemer AB; Zivin JA
Vasc Health Risk Manag; 2010 Apr; 6():229-36. PubMed ID: 20407630
[TBL] [Abstract][Full Text] [Related]
25. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
[TBL] [Abstract][Full Text] [Related]
26. The atorvastatin during ischemic stroke study: a pilot randomized controlled trial.
Muscari A; Puddu GM; Santoro N; Serafini C; Cenni A; Rossi V; Zoli M
Clin Neuropharmacol; 2011; 34(4):141-7. PubMed ID: 21677574
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the Efficacy of Atorvastatin on Patients with Carotid Plaque by an Innovative Ultrasonography.
Zhu YC; Jiang XZ; Bai QK; Deng SH; Zhang Y; Zhang ZP; Jiang Q
J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):830-837. PubMed ID: 30563776
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
[TBL] [Abstract][Full Text] [Related]
29. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
[TBL] [Abstract][Full Text] [Related]
30. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G
Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438
[TBL] [Abstract][Full Text] [Related]
31. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
[TBL] [Abstract][Full Text] [Related]
32. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease.
Yu CM; Zhang Q; Lam L; Lin H; Kong SL; Chan W; Fung JW; Cheng KK; Chan IH; Lee SW; Sanderson JE; Lam CW
Heart; 2007 Aug; 93(8):933-9. PubMed ID: 17344325
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty.
Kougialis S; Skopelitis E; Gialernios T; Nikolaou S; Kroustalis A; Katsadorou E; Gialernios K; Zervou A; Gika E; Polydorou A; Polydorou V; Drakoulis C; Iliopoulos N; Dermitzakis I; Mpilinis H; Polydorou A
Int Angiol; 2010 Aug; 29(4):338-47. PubMed ID: 20671652
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin in prevention of stroke and transient ischaemic attack.
Amarenco P
Expert Opin Pharmacother; 2007 Nov; 8(16):2789-97. PubMed ID: 17956199
[TBL] [Abstract][Full Text] [Related]
35. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.
Zhao XQ; Dong L; Hatsukami T; Phan BA; Chu B; Moore A; Lane T; Neradilek MB; Polissar N; Monick D; Lee C; Underhill H; Yuan C
JACC Cardiovasc Imaging; 2011 Sep; 4(9):977-86. PubMed ID: 21920335
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of computed tomography angiography plaque thickness measurements in high-grade carotid artery stenosis.
Gupta A; Baradaran H; Kamel H; Pandya A; Mangla A; Dunning A; Marshall RS; Sanelli PC
Stroke; 2014 Mar; 45(3):740-5. PubMed ID: 24496392
[TBL] [Abstract][Full Text] [Related]
37. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML;
N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131
[TBL] [Abstract][Full Text] [Related]
38. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study.
Yokoyama M; Komiyama N; Courtney BK; Nakayama T; Namikawa S; Kuriyama N; Koizumi T; Nameki M; Fitzgerald PJ; Komuro I
Am Heart J; 2005 Aug; 150(2):287. PubMed ID: 16086932
[TBL] [Abstract][Full Text] [Related]
39. Stroke--an equal opportunity for the initiation of statin therapy.
Kent DM
N Engl J Med; 2006 Aug; 355(6):613-5. PubMed ID: 16899782
[No Abstract] [Full Text] [Related]
40. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month.
Martín-Ventura JL; Blanco-Colio LM; Gómez-Hernández A; Muñoz-García B; Vega M; Serrano J; Ortega L; Hernández G; Tuñón J; Egido J
Stroke; 2005 Aug; 36(8):1796-800. PubMed ID: 16020773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
